Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cellular and Molecular Biology

• Publication date

  2003-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12887096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predominant expression of type II vasoactive intestinal peptide receptors by human T lymphoblastoma cells: Transduction of both Ca2+ and cyclic AMP signals

  2005cited by this paper
• Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats, and human subjects

  2004cited by this paper
• Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice1

  2003cited by this paper
• Neuroendocrine regulation of immunity.

  2003cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit the production of inflammatory mediators by activated microglia

  2003cited by this paper
• Vasoactive intestinal peptide inhibits IL-8 production in human monocytes.

  2003cited by this paper
• Pituitary Adenylate-Cyclase-Activating Polypeptide Expression in the Immune System

  2002cited by this paper
• Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development.

  2002cited by this paper
• Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10.

  2002cited by this paper
• Sympathetic nervous system interaction with the immune system.

  2002cited by this paper
• Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity.

  2002cited by this paper
• IL-4 inhibits vasoactive intestinal peptide production by macrophages.

  2002cited by this paper
• TH1/TH2 CYTOKINES IN THE CENTRAL NERVOUS SYSTEM

  2002cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-kappaB interaction in activated microglia.

  2002cited by this paper
• Human bone marrow angiogenesis: in vitro modulation by substance P and neurokinin A

  2002cited by this paper
• Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor.

  2002cited by this paper
• VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells.

  2002cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression.

  2002cited by this paper
• Peptidergic and nitrergic inhibitory neurotransmissions in the hamster jejunum: regulation of vasoactive intestinal peptide release by nitric oxide.

  2002cited by this paper
• Neuropeptides and Nerve Growth in Inflammatory Bowel Diseases: A Quantitative Immunohistochemical Study

  2002cited by this paper
• Neuroendocrine Function and Chronic Inflammatory Stress

  2002cited by this paper
• Direct and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids1

  2002cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit chemokine production in activated microglia

  2002cited by this paper
• The inflammatory reflex

  2002cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia.

  2002cited by this paper
• Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo.

  2001cited by this paper
• Inhibition of Endotoxin-Induced Macrophage Chemokine Production by Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide In Vitro and In Vivo1

  2001cited by this paper
• Transforming Growth Factor-β and Ciliary Neurotrophic Factor Synergistically Induce Vasoactive Intestinal Peptide Gene Expression through the Cooperation of Smad, STAT, and AP-1 Sites*

  2001cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.

  2001cited by this paper
• Selective Gene Expression and Activation-Dependent Regulation of Vasoactive Intestinal Peptide Receptor Type 1 and Type 2 in Human T Cells1

  2001cited by this paper
• Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide

  2001cited by this paper
• Cutting Edge: Is Vasoactive Intestinal Peptide a Type 2 Cytokine?

  2001cited by this paper
• Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor

  2001cited by this paper
• Inhibitory neuropeptide receptors on macrophages.

  2001cited by this paper
• Identification of a Novel gp130-responsive Site in the Vasoactive Intestinal Peptide Cytokine Response Element*

  2000cited by this paper
• Inhibition of IFN-γ-Induced Janus Kinase-1-STAT1 Activation in Macrophages by Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide

  2000cited by this paper
• In vitro and in vivo regulation of chemokine receptors.

  2000cited by this paper
• Immunobiology of vasoactive intestinal peptide (VIP)

  2000cited by this paper
• The neuropeptides VIP and PACAP inhibit IL-2 transcription by decreasing c-Jun and increasing JunB expression in T cells.

  2000cited by this paper
• Immunology of VIP: a review and therapeutical perspectives.

  2000cited by this paper
• Somatostatin and Substance P Induced in vivo by Lipopolysaccharide and in Peritoneal Macrophages Stimulated with Lipopolysaccharide or Interferon-Gamma Have Differential Effects on Murine Cytokine Production

  2000cited by this paper
• Chemokines: a new classification system and their role in immunity.

  2000cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.

  2000cited by this paper
• Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?

  2000cited by this paper
• The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.

  2000cited by this paper
• Vasoactive Intestinal Peptide and Pituitary Adenylyl Cyclase-Activating Polypeptide Inhibit Tumor Necrosis Factor-α Production in Injured Spinal Cord and in Activated Microglia via a cAMP-Dependent Pathway

  2000cited by this paper
• Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Antigen-Induced Apoptosis of Mature T Lymphocytes by Inhibiting Fas Ligand Expression1

  2000cited by this paper
• IL‐4 regulates VIP receptor subtype 2 mRNA (VPAC2) expression in T cells in murine schistosomiasis

  2000cited by this paper
• Regulation of VIP production and secretion by murine lymphocytes.

  1999cited by this paper
• Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Interleukin-12 Transcription by Regulating Nuclear Factor κB and Ets Activation*

  1999cited by this paper
• VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.

  1999cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.

  1999cited by this paper
• VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells.

  1999cited by this paper
• Catecholaminergic, cholinergic and peptidergic innervation of gut-associated lymphoid tissue in porcine jejunum and ileum

  1999cited by this paper
• Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.

  1999cited by this paper
• Distinct patterns and kinetics of chemokine production regulate dendritic cell function

  1999cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.

  1999cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.

  1999cited by this paper
• Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages.

  1998cited by this paper
• Selectivity of Effects of Vasoactive Intestinal Peptide on Macrophages and Lymphocytes in Compartmental Immune Responses a

  1998cited by this paper
• Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

  1998cited by this paper
• Cytokines induce the development of functionally heterogeneous T helper cell subsets.

  1998cited by this paper
• Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes.

  1998cited by this paper
• CCR5 is characteristic of Th1 lymphocytes

  1998cited by this paper
• VIP1 and VIP2 Receptors but not PVR1 Mediate the Effect of VIP/PACAP on Cytokine Production in T Lymphocytes

  1998cited by this paper
• STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13.

  1998cited by this paper
• Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat.

  1998cited by this paper
• Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses.

  1998cited by this paper
• Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun*

  1998cited by this paper
• Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses.

  1998cited by this paper
• The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.

  1998cited by this paper
• Integration of Jak-Stat and AP-1 Signaling Pathways at the Vasoactive Intestinal Peptide Cytokine Response Element Regulates Ciliary Neurotrophic Factor-dependent Transcription*

  1997cited by this paper
• Differential ability of T cell subsets to undergo activation-induced cell death.

  1997cited by this paper
• Vasoactive intestinal polypeptide (VIP) innervation of rat spleen, thymus, and lymph nodes.

  1997cited by this paper
• Neural-immune interactions in health and disease.

  1997cited by this paper
• Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis

  1997cited by this paper
• Calcitonin gene‐related peptide, substance P, and tyrosine hydroxylase‐immunoreactive innervation of rat bone marrows: An immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms

  1997cited by this paper
• Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma.

  1997cited by this paper
• Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.

  1997cited by this paper
• T cell vasoactive intestinal peptide receptor subtype expression differs between granulomas and spleen of schistosome-infected mice.

  1996cited by this paper
• Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

  1996cited by this paper
• alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line.

  1996cited by this paper
• B7-2 (CD86) is essential for the development of IL-4-producing T cells.

  1996cited by this paper
• Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA.

  1996cited by this paper
• Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.

  1996cited by this paper
• Regulation of VIP release from rat enteric nerve terminals: evidence for a stimulatory effect of NO.

  1996cited by this paper
• Noradrenergic and peptidergic innervation of the mouse femur bone marrow.

  1996cited by this paper
• Differences in Nuclear Signaling by Leukemia Inhibitory Factor and Interferon‐γ: The Role of STAT Proteins in Regulating Vasoactive Intestinal Peptide Gene Expression

  1995cited by this paper
• Substance P‐immunoreactive and protein gene product 9.5‐immunoreactive nerve fibres in bone marrow of rat coccygeal vertebrae

  1994cited by this paper
• Neuropeptide Y is an inducible gene in the human immune system.

  1994cited by this paper
• Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes.

  1994cited by this paper
• Immunohistochemical localization of peptidergic nerve fibers and neuropeptide receptors in Peyer's patches of the cat ileum.

  1994cited by this paper
• Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: evidence for regulation of vasoactive intestinal peptide release by nitric oxide.

  1993cited by this paper
• Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system.

  1993cited by this paper
• Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.

  1993cited by this paper
• Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma.

  1992cited by this paper
• Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception.

  1992cited by this paper
• Expression of atrial natriuretic peptide in thymic macrophages after dexamethasone treatment of rats

  1992cited by this paper
• Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis.

  1992cited by this paper
• Localization of calcitonin gene-related peptide in human esophageal Langerhans cells.

  1991cited by this paper

• Neuropeptides or their receptors in pathogenesis of lung diseases and therapeutic potentials.

  2024cites this paper
• The neuropeptide PACAP alleviates T. gondii infection-induced neuroinflammation and neuronal impairment

  2022cites this paper
• Obesity-related gut hormones and cancer: novel insight into the pathophysiology

  2021influential citation
• Current views on neuropeptides in atopic dermatitis

  2021cites this paper
• Vasoactive Intestinal Peptide Immunoregulatory Role at the Periapex: Associative and Mechanistic Evidences from Human and Experimental Periapical Lesions.

  2019cites this paper
• Neuro-immune crosstalk and allergic inflammation.

  2019cites this paper
• Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses

  2018cites this paper
• Evaluation of Immune-Modulating Therapies For Parkinson's Disease

  2017cites this paper
• In situ proximity of CX3CR1-positive mononuclear phagocytes and VIP-ergic nerve fibers suggests VIP-ergic immunomodulation in the mouse ileum

  2017cites this paper
• Bilateral tactile hypersensitivity and neuroimmune responses after spared nerve injury in mice lacking vasoactive intestinal peptide

  2017cites this paper
• Immunomodulation by Vasoactive Intestinal Polypeptide (VIP)

  2016cites this paper
• Vasoactive Intestinal Peptide Promotes Immune Escape of MKN45 Cells by Inhibiting Antigen-Presenting Molecules of Dendritic Cells In Vitro

  2016cites this paper
• Immunobiology of the Pituitary Adenylate Cyclase-Activating Peptide

  2016cites this paper
• Effects of Exogenous PACAP in Small Bowel Ischemia – Reperfusion Injury in Rats

  2016cites this paper
• Protective Intestinal Effects of Pituitary Adenylate Cyclase Activating Polypeptide

  2016cites this paper
• Study of genes associated with the ‘anger-in’ and ‘anger-out’ emotions of humans using a rat model

  2015cites this paper
• Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice

  2015cites this paper
• The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases

  2015cites this paper
• Neuro-Endocrine Networks Controlling Immune System in Health and Disease

  2014cites this paper
• Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.

  2014cites this paper
• Evidence for pituitary adenylate cyclase-activating peptide as a direct immunoregulator in teleost head kidney.

  2013cites this paper
• The specific VPAC2 agonist Bay 55-9837 increases neuronal damage and hemorrhagic transformation after stroke in type 2 diabetic rats.

  2013cites this paper
• Chapter 175 – PACAP

  2013cites this paper
• Pituitary adenylate cyclase‐activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate

  2012influential citation
• Vasoactive Intestinal Peptide: Immune Mediator and Potential Therapeutic Agent

  2012cites this paper
• Nerve-Driven Immunity

  2012cites this paper
• Stress-related programming of autonomic imbalance: role in allergy and asthma.

  2012cites this paper
• Effects of pituitary adenylate cyclase activating polypeptide on CD4(+)/CD8(+) T cell levels after traumatic brain injury in a rat model.

  2012cites this paper
• Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions

  2011cites this paper
• Activation of the VIP/VPAC2 system induces reactive astrocytosis associated with increased expression of glutamate transporters.

  2011cites this paper
• Regulation of IgA responses in cattle, humans and mice.

  2010cites this paper
• Alterations of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth

  2010cites this paper
• Die Blockade des Neuropilin-2 als mögliches therapeutisches Prinzip bei Arthritis

  2010cites this paper
• Human IgA-Inducing Protein from Dendritic Cells Induces IgA Production by Naive IgD+ B Cells1

  2009cites this paper
• Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms

  2009cites this paper
• Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions.

  2008cites this paper
• A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells

  2008cites this paper
• A novel VIP signaling pathway in T cells cAMP-->protein tyrosine phosphatase (SHP-2?)-->JAK2/STAT4-->Th1 differentiation.

  2007cites this paper
• CHAPTER 4 – Significance of Sensory Neuropeptides and the Immune Response

  2007cites this paper
• Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells.

  2007cites this paper
• Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

  2007cites this paper
• Bidirectional Communication Between the Brain and the Immune System

  2007cites this paper
• Physiologie de la médullosurrénale

  2007cites this paper
• Pivotal Advance: Vasoactive intestinal peptide inhibits up‐regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages

  2007cites this paper
• CHAPTER 5 – Vasoactive Intestinal Peptide: An Anti-inflammatory Neuropeptide

  2007cites this paper
• Nephrology beyond JASN

  2006cites this paper
• Postulated Vasoactive Neuropeptide Autoimmunity in Fatigue-Related Conditions: A Brief Review and Hypothesis

  2006cites this paper
• Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems.

  2006cites this paper
• New Insights into the Central PACAPergic System from the Phenotypes in PACAP‐ and PACAP Receptor‐Knockout Mice

  2006cites this paper
• Human VIP-α: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension

  2006cites this paper
• The role of protein kinase A and A-kinase anchoring proteins in modulating T-cell activation: progress and future directions.

  2006cites this paper
• Neuroendocrine Regulation of Skin Dendritic Cells

  2006cites this paper
• A Novel Mechanism for Immunosuppression: from Neuropeptides to Regulatory T Cells

  2006cites this paper
• Vasoactive Intestinal Peptide

  2006cites this paper
• Expression of pituitary adenylate cyclase‐activating polypeptide in the primary lymphoid organs of the duck Anas platyrhynchos

  2006cites this paper
• Vasoactive intestinal peptide generates CD4CD25 regulatory T cells in vivo

  2005cites this paper
• Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts.

  2005cites this paper
• VIP Inhibits Porphyromonas gingivalis LPS-induced Immune Responses in Human Monocytes

  2005cites this paper
• Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

  2005cites this paper
• Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?

  2005cites this paper
• VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells

  2004cites this paper
• Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide.

  2004cites this paper
• Restoration of axotomy-induced PACAP gene induction in SCID mice with CD4+ T-lymphocytes

  2004cites this paper
• Therapeutic approaches of vasoactive intestinal peptide as an immunomodulatory cytokine

  2004cites this paper
• The Significance of Vasoactive Intestinal Peptide in Immunomodulation

  2004influential citation
• An "eye" in the gut: the appendix as a sentinel sensory organ of the immune intelligence network.

  2004cites this paper
• VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells

  2004cites this paper